PD03-09 SAFETY AND FEASIBILITY OF NEPHRECTOMY AFTER RECEIPT OF IMMUNE CHECKPOINT INHIBITORS FOR RENAL CELL CARCINOMA

INTRODUCTION AND OBJECTIVES:With the approval of immune checkpoint inhibitors (ICI) for metastatic renal cell carcinoma (RCC), the role, timing, and safety of surgically excising the primary tumor ...